These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30411028)

  • 1. Assessment of the Physical Properties of Inclusion Complexes of Forchlorfenuron and γ-Cyclodextrin Derivatives and Their Promotion of Plant Growth.
    Inoue Y; Hirano A; Murata I; Kobata K; Kanamoto I
    ACS Omega; 2018 Oct; 3(10):13160-13169. PubMed ID: 30411028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
    Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
    J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Spectroscopic Characterization of Inclusion Complexes of 3D Ball-Milled Rifampicin with β-cyclodextrin and γ-cyclodextrin : 3D Ball-Milled Rifampicin with β-cyclodextrin and γ-cyclodextrin.
    Inoue Y; Shigematsu M; Komatsu T; Oguchi T; Arce FJ; See GL
    AAPS PharmSciTech; 2022 May; 23(5):138. PubMed ID: 35534746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Dissolution Behavior of Piperine/Cyclodextrins Inclusion Complexes.
    Ezawa T; Inoue Y; Murata I; Takao K; Sugita Y; Kanamoto I
    AAPS PharmSciTech; 2018 Feb; 19(2):923-933. PubMed ID: 29071656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antioxidant activity of caffeic acid with cyclodextrins using ground mixture method.
    Shiozawa R; Inoue Y; Murata I; Kanamoto I
    Asian J Pharm Sci; 2018 Jan; 13(1):24-33. PubMed ID: 32104375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Solubility Characteristics of a Hybrid Complex of Components of Soy.
    Inoue Y; Osada M; Murata I; Kobata K; Kanamoto I
    ACS Omega; 2019 May; 4(5):8632-8640. PubMed ID: 31459952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the Solubility and Evaluation of the Physical Properties of an Inclusion Complex Formed by a New Ferulic Acid Derivative and γ-Cyclodextrin.
    Ikeda N; Inoue Y; Ogata Y; Murata I; Meiyan X; Takayama J; Sakamoto T; Okazaki M; Kanamoto I
    ACS Omega; 2020 Jun; 5(21):12073-12080. PubMed ID: 32548386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility of Piperine and Its Inclusion Complexes in Biorelevant Media and Their Effect on Attenuating Mouse Ileum Contractions.
    Ezawa T; Inagaki Y; Kashiwaba K; Matsumoto N; Moteki H; Murata I; Inoue Y; Kimura M; Ogihara M; Kanamoto I
    ACS Omega; 2021 Mar; 6(10):6953-6964. PubMed ID: 33748609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
    Jansook P; Pichayakorn W; Muankaew C; Loftsson T
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization, Preparation, and Promotion of Plant Growth of 1,3-Diphenylurea/β-Cyclodextrin Derivatives Inclusion Complexes.
    Yamamoto K; Tanikawa T; Tomita J; Ishida Y; Nakata D; Terao K; Inoue Y
    ACS Omega; 2023 Sep; 8(38):34972-34981. PubMed ID: 37779935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gammaCD/HPgammaCD: synergistic solubilization.
    Jansook P; Loftsson T
    Int J Pharm; 2008 Nov; 363(1-2):217-9. PubMed ID: 18691643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].
    Zhang YM; Li X; Sun CS; Chen CF
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and Physico-Chemical Evaluation of Nifedipine-hydroxypropyl-β-cyclodextrin and Nifedipine-methyl-β-cyclodextrin: The Development of Orodispersible Tablets.
    Ozon EA; Novac M; Gheorghe D; Musuc AM; Mitu MA; Sarbu I; Anuta V; Rusu A; Petrescu S; Atkinson I; Lupuliasa D
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion Complexes of Rifampicin with Native and Derivatized Cyclodextrins:
    Anjani QK; Domínguez-Robles J; Utomo E; Font M; Martínez-Ohárriz MC; Permana AD; Cárcamo-Martínez Á; Larrañeta E; Donnelly RF
    Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, Characterization, and In Vitro Evaluation of Inclusion Complexes Formed between
    Tachikawa R; Saito H; Moteki H; Kimura M; Kitagishi H; Arce F; See GL; Tanikawa T; Inoue Y
    ACS Omega; 2022 Sep; 7(35):31233-31245. PubMed ID: 36092555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions of the inclusion complexes of hinokitiol and various cyclodextrins.
    Suzuki R; Inoue Y; Limmatvapirat S; Murata I; Kanamoto I
    AAPS PharmSciTech; 2017 Oct; 18(7):2717-2726. PubMed ID: 28299622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes.
    Novac M; Musuc AM; Ozon EA; Sarbu I; Mitu MA; Rusu A; Gheorghe D; Petrescu S; Atkinson I; Lupuliasa D
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A; Londhe V
    Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.